Search Results - "Llorente L"

Aging‐related biomarkers in testicular cancer survivors after different oncologic treatments.

Authors: Carballo‐Muñoz, A. Lima, G. Llorente, L. et al.

Source: Cancer Medicine. Sep2024, Vol. 13 Issue 18, p1-11. 11p.

Optimal conditions in [³H]-thymidine uptake studies to prevent radiation damage to cells. A scintimetric and cytofluorographic analysis.

Authors: Ruiz-Arguelles, A. Llorente, L. E. Díaz-Jouanen et al.

Source: Immunology. Dec81, Vol. 44 Issue 4, p811-815. 5p.

This result is not displayed to guests.
Login for full access.

HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis.

Authors: Garcia-Ramos, G. Tellez-Zenteno, J.F. Zapata-Zuniga, M. et al.

Source: European Journal of Neurology. Nov2003, Vol. 10 Issue 6, p707. 4p.

Subjects: HLA class II antigens, Myasthenia gravis, Mestizos

Geographic Terms: Mexico

This result is not displayed to guests.
Login for full access.

Profile of cytokine mRNA expression in spontaneous and UV-induced skin lesions from actinic prurigo patients.

Authors: Santos-Martínez, L. Llorente, L. Baranda, L. et al.

Source: Experimental Dermatology. Apr97, Vol. 6 Issue 2, p91-97. 7p.

Antibody penetration into living cells. IV. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated Tγ cells.

Authors: Alarcón-Segovia, D. Llorente, L.

Source: Clinical & Experimental Immunology. May1983, Vol. 52 Issue 2, p365-371. 7p.

Effect of rapamycin on cytokine profile in kidney transplant recipients treated with triple drug therapy

Authors: Morales-Buenrostro, L.E. Llorente, L. Richaud-Patin, Y. et al.

Source: Transplantation Proceedings. Jul2004, Vol. 36 Issue 6, p1661-1663. 3p.

This result is not displayed to guests.
Login for full access.

Myelitis in systemic lupus erythematosus: clinical characteristics and effect in accrual damage. A single-center experience.

Authors: Quintanilla-Gonzélez, L. Atisha-Fregoso, Y. Llorente, L. et al.

Source: Lupus. 3/1/2017, Vol. 26 Issue 3, p248-254. 7p. 4 Charts.

Thyroid hormone receptor β1 domains responsible for the antagonism with the ras oncogene: role of corepressors.

Authors: García-Silva, S Martínez-Iglesias, O Ruiz-Llorente, L et al.

Source: Oncogene. 2/17/2011, Vol. 30 Issue 7, p854-864. 11p. 8 Black and White Photographs, 1 Graph.

Human post-thymic precursor cells in health and disease I. CHARACTERIZATION OF THE AUTOLOGOUS ROSETTE-FORMING T CELLS AS POST-THYMIC PRECURSORS.

Authors: Palacios, R. Alarcón-Segovia, D. Llorente, L. et al.

Source: Immunology. Jan81, Vol. 42 Issue 1, p127-135. 9p.

P158 Pregnancy management after nutcracker syndrome treated with vascular stent

Authors: Zapardiel, I. Sanfrutos-Llorente, L. Perez-Medina, T. et al.

Source: International Journal of Gynecology & Obstetrics. Oct2009 Supplement 2, Vol. 107, pS456-S456. 1p.

Exhausted T cells in systemic lupus erythematosus patients in long‐standing remission.

Authors: Lima, G. Treviño‐Tello, F. Atisha‐Fregoso, Y. et al.

Source: Clinical & Experimental Immunology. Jun2021, Vol. 204 Issue 3, p285-295. 11p. 1 Color Photograph, 4 Charts, 1 Graph.

Pneumonia in patients with systemic lupus erythematosus: Epidemiology, microbiology and outcomes.

Authors: García-Guevara, G. Ríos-Corzo, R. Díaz-Mora, A. et al.

Source: Lupus. Dec2018, Vol. 27 Issue 12, p1953-1959. 7p. 5 Charts, 1 Graph.

Presence of an IL-3-producing suppressor T cell resistant to cyclosporin A in the peripheral blood of patients with systemic lupus erythematosus.

Authors: Alcocer-Varela Vidaller, A. Llorente, L. et al.

Source: Clinical & Experimental Immunology. Aug1988, Vol. 73 Issue 3, p424-429. 6p.

Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.

Authors: Fragoso-Loyo, H. Atisha-Fregoso, Y. Nuñez-Alvarez, C. A. et al.

Source: Lupus. Apr2016, Vol. 25 Issue 4, p364-369. 6p. 2 Charts, 1 Graph.

VALORACIÓN ÉTICA DE LA CRANEOPLASTIA CON VENDAJE COMPRESIVO COMO FORMA DE LIMITACIÓN DE TRATAMIENTOS DE SOPORTE VITAL.

Alternate Title: Ethical value of cranioplasty with oppressive binder as a way of limiting life support treatments.
Valoração ética da cranioplastia com curativo compressivo como forma de limitação de tratamentos de suporte vital.

Authors: Canabal Berlanga, Alfonso Jara Rascón, José Gómez Rodríguez, Rafael et al.

Source: Acta Bioéthica. 2015, Vol. 21 Issue 2, p183-189. 7p.

Assessment of the toxic effects of 2-dodecanone in the insect model species Drosophila melanogaster.

Authors: Aquilino, M. Planelló, R. LLorente, L. et al.

Source: Toxicology Letters. 2021 Supplement, Vol. 350, pS182-S182. 1p.

Differential Cytokine Expression and Regulatory Cells in Patients with Primary and Secondary Sjögren's Syndrome.

Authors: Furuzawa‐Carballeda, J. Sánchez‐Guerrero, J. Betanzos, J. L. et al.

Source: Scandinavian Journal of Immunology. Dec2014, Vol. 80 Issue 6, p432-440. 9p.